PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 8
- Registration Number
- NCT06340347
- Locations
- 🇺🇸
Orange County Research Center, Lake Forest, California, United States
🇺🇸Genesis Clinical Research, LLC, Tampa, Florida, United States
🇺🇸Thomas Jefferson University-Pharmacology, Physiology and Cancer Biology, Philadelphia, Pennsylvania, United States
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin
- Conditions
- Healthy
- Interventions
- Drug: PF-07054894 or placebo
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 6
- Registration Number
- NCT06327880
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants
- Conditions
- Respiratory Syncytial Virus
- Interventions
- Biological: Placebp
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 343
- Registration Number
- NCT06325657
- Locations
- 🇿🇦
Setshaba Research Centre, Tshwane, Gauteng, South Africa
🇿🇦Synergy Biomed Research Institute, East London, Eastern CAPE, South Africa
🇿🇦Josha Research, Bloemfontein, FREE State, South Africa
A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- Conditions
- Transthyretin Amyloid Cardiomyopathy
- Interventions
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 13
- Registration Number
- NCT06321523
- Locations
- 🇰🇷
Pfizer, Seoul, Korea, Republic of
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
- Conditions
- Lung Cancer
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 100
- Registration Number
- NCT06321510
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT06307457
- Locations
- 🇩🇰
Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 600
- Registration Number
- NCT06297161
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 260
- Registration Number
- NCT06294925
- Locations
- 🇩🇪
Praxis Heil und Müller, Andernach, Germany
🇬🇧Imperial College Healthcare NHS, London, United Kingdom
🇬🇧University College London Hospital, London, United Kingdom
A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3000
- Registration Number
- NCT06291831
- Locations
- 🇧🇭
Pfizer Gulf FZ, Busaiteen, Bahrain
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
- Conditions
- MelanomaUrothelial CarcinomaColorectal CarcinomaNeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and NeckRenal Cell CarcinomaOvarian Carcinoma
- Interventions
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 9
- Registration Number
- NCT06285097
- Locations
- 🇺🇸
Florida Cancer Specialists Sarasota Drug Development Unit, Sarasota, Florida, United States
🇺🇸Corewell Health (reference non-engagement letter), Grand Rapids, Michigan, United States
🇺🇸START Midwest, Grand Rapids, Michigan, United States